Back to announcement
20250327_HEAL_Laporan Informasi dan Fakta Material_31872164_lamp1.pdf
Ownership change Needs review HEALSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
PT MEDIKALOKA HERMINA Tbk
Kantor Pusat: Jl. Raya Jatinegara Barat No. 126 Jatinegara, Jakarta Timur 13320
Kantor Cabang: Hermina Tower I Lt. 10 Jl. Selangit Blok B-10 Kav. 04, Kemayoran, Jakarta Pusat 10610
Telp. 021-39702255 Website : www.herminahospitals.com
Jakarta, 27 Maret 2025
Nomor : 165/DIR/MH/III/2025
Kepada Yth.
PT Bursa Efek Indonesia
Gedung Bursa Efek Indonesia
Indonesia Stock Exchange Building Tower I, 6th Floor
Jl. Jend. Sudirman Kav. 52-53
Jakarta 12190
U.p.: Ibu Mita Dwijayanti (PH Kepala Divisi PP3)
Dengan hormat,
Sehubungan dengan surat dari Bursa Efek Indonesia No. S-02996/BEI.PP3/03-2025 tanggal 25
Maret 2025 perihal Permintaan Penjelasan Atas Volatilitas Transaksi Efek, melalui surat ini kami
sampaikan jawaban kami atas poin-poin yang ditanyakan di dalam surat tersebut, sebagai
berikut:
1. Apakah Perseroan mengetahui adanya informasi atau fakta material yang dapat
mempengaruhi nilai efek perusahaan atau keputusan investasi pemodal sebagaimana
diatur dalam Peraturan Otoritas Jasa Keuangan Nomor 31/POJK.04/2015 Tentang
Keterbukaan Informasi Atau Fakta Material Oleh Emiten Atau Perusahaan Publik?
Dalam kurun waktu 18 s/d 24 Maret 2025, Perseroan tidak memiliki informasi atau fakta
material yang perlu dilaporkan kepada pasar.
2. Apakah Perseroan mengetahui adanya informasi atau fakta material yang dapat
mempengaruhi nilai efek perusahaan atau keputusan investasi pemodal sebagaimana
diatur dalam Peraturan Nomor I-E: Kewajiban Penyampaian Informasi ketentuan butir
point III.2.1. dan IV.2.1. Lampiran Keputusan Direksi PT Bursa Efek Indonesia Kep-
00015/BEI/01-2021?
Dalam kurun waktu 18 s/d 24 Maret 2025, Perseroan tidak memiliki informasi atau fakta
material yang perlu dilaporkan kepada pasar.
3. Informasi/fakta/kejadian penting lainnya yang material dan dapat mempengaruhi harga
efek Perseroan serta kelangsungan hidup Perseroan yang belum diungkapkan kepada
publik.
Dalam kurun waktu 18 s/d 24 Maret 2025, Perseroan tidak memiliki informasi atau fakta
material yang perlu dilaporkan kepada pasar.
4. Apakah Perseroan mengetahui adanya aktivitas dari pemegang saham tertentu
sebagaimana diatur dalam Peraturan Otoritas Jasa Keuangan Nomor 11/POJK.04/2017
Tentang Laporan Kepemilikan atau Setiap Perubahan Kepemilikan Saham Perusahaan
Terbuka.
Kami tidak melihat ada aktifitas pemegang saham tertentu dalam kurun waktu 18 s/d 24 Maret
2024. Kami melihat aktifitas perdagangan saham HEAL sejalan dengan kondisi pasar yang
cenderung menurun pada kurun waktu tersebut.
Page 2
PT MEDIKALOKA HERMINA Tbk
Kantor Pusat: Jl. Raya Jatinegara Barat No. 126 Jatinegara, Jakarta Timur 13320
Kantor Cabang: Hermina Tower I Lt. 10 Jl. Selangit Blok B-10 Kav. 04, Kemayoran, Jakarta Pusat 10610
Telp. 021-39702255 Website : www.herminahospitals.com
5. Apakah Perseroan memiliki rencana untuk melakukan tindakan korporasi dalam waktu
dekat, termasuk rencana korporasi yang akan berakibat terhadap pencatatan saham
Perseroan di Bursa (paling tidak dalam 3 bulan mendatang)?
Tidak ada rencana aksi korporasi dalam kurun waktu tiga bulan mendatang. Seluruh rencana
tindakan aksi korporasi akan dilaporkan kepada Bursa sesuai dengan peraturan yang berlaku.
6. Rencana pemegang saham utama terkait dengan kepemilikan sahamnya di Perseroan.
Dalam hal ini, mohon kiranya Corporate Secretary menanyakan terlebih dahulu kepada
pemegang saham utama dalam menjawab konfirmasi tersebut?
Tidak ada rencana khusus dari pemegang saham utama kami. Seluruh rencana pemegang
saham utama yang berkaitan dengan pasar akan dilaporkan dan tunduk dalam peraturan-
peraturan pasar modal yang berlaku.
Demikian disampaikan, atas perhatiannya diucapkan terima kasih.
Hormat kami,
Yulisar Khiat
Wakil Direktur Utama – Keuangan dan Pengembangan Strategik
Page 3
PT MEDIKALOKA HERMINA Tbk
Kantor Pusat: Jl. Raya Jatinegara Barat No. 126 Jatinegara, Jakarta Timur 13320
Kantor Cabang: Hermina Tower I Lt. 10 Jl. Selangit Blok B-10 Kav. 04, Kemayoran, Jakarta Pusat 10610
Telp. 021-39702255 Website : www.herminahospitals.com
Jakarta, 27 March 2025
Nomor : 165/DIR/MH/III/2025
To.
PT Bursa Efek Indonesia
Gedung Bursa Efek Indonesia
Indonesia Stock Exchange Building Tower I, 6th Floor
Jl. Jend. Sudirman Kav. 52-53
Jakarta 12190
Attn. to: Ibu Mita Dwijayanti (PH Kepala Divisi PP3)
Dear Sirs,
In relation to the letter from the Indonesia Stock Exchange No. S-02996/BEI.PP3/03-2025 dated
March 25, 2025 regarding the Request for Explanation of Securities Transaction Volatility, through
this letter we convey our answers to the points asked in the letter, as follows:
1. Is the Company aware of any material information or facts that may affect the value of
the company's securities or investor investment decisions as stipulated in Financial
Services Authority Regulation Number 31/POJK.04/2015 Concerning Disclosure of
Material Information or Facts by Issuers or Public Companies?
During the period 18 to 24 March 2025, the Company did not have any material information
or facts that needed to be reported to the market.
2. Is the Company aware of any material information or facts that may affect the value of
the company's securities or the investor's investment decision as stipulated in
Regulation Number I-E: Obligation to Submit Information provisions of points III.2.1.
and IV.2.1. Attachment to the Decree of the Board of Directors of PT Bursa Efek
Indonesia Kep-00015/BEI/01-2021?
During the period 18 to 24 March 2025, the Company did not have any material information
or facts that needed to be reported to the market.
3. Other important information/facts/events that are material and may affect the price of
the Company's securities and the Company's survival that have not been disclosed to
the public.
During the period 18 to 24 March 2025, the Company did not have any material information
or facts that needed to be reported to the market.
4. Is the Company aware of any activities from certain shareholders as stipulated in
Financial Services Authority Regulation Number 11/POJK.04/2017 Concerning
Ownership Reports or Any Changes in Share Ownership of Public Companies.
We do not see any specific shareholder activity during the period from 18 to 24 March 2024.
We see HEAL stock trading activity in line with market conditions which tend to decline during
that period.
Page 4
PT MEDIKALOKA HERMINA Tbk
Kantor Pusat: Jl. Raya Jatinegara Barat No. 126 Jatinegara, Jakarta Timur 13320
Kantor Cabang: Hermina Tower I Lt. 10 Jl. Selangit Blok B-10 Kav. 04, Kemayoran, Jakarta Pusat 10610
Telp. 021-39702255 Website : www.herminahospitals.com
5. Does the Company have plans to undertake corporate actions in the near future,
including corporate plans that will result in the listing of the Company's shares on the
Stock Exchange (at least in the next 3 months)?
There are no corporate action plans within the next three months. All corporate action plans
will be reported to the Exchange in accordance with applicable regulations.
6. The plan of the major shareholders is related to their share ownership in the Company.
In this case, would the Corporate Secretary please ask the major shareholders first in
answering the confirmation?
There are no special plans from our main shareholders. All major shareholder plans relating
to the market will be reported and subject to applicable capital market regulations.
Thank you,
Yulisar Khiat
Vice President Director – Finance and Strategic Development
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Indonesia Stock Exchange
p.1 ×3
unresolved
person
Mita Dwijayanti
p.1 ×2
unresolved
org
Financial Services Authority
p.3 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.059
1870 ms
12 Sep 2026 22:52
Raw output
{'is_controller': None,
'issuer_name': '',
'issuer_raw': '',
'issuer_ticker': '',
'lines': [],
'pct_after': None,
'pct_before': None,
'report_date': None,
'report_number': '165/DIR/MH/III/2025',
'reporter_is_board_member': None,
'reporter_name': '',
'reporter_nationality': '',
'reporter_position': '',
'retains_control': None,
'shares_after': None,
'shares_before': None}